来自MSN6 个月
Mankind Pharma trumps EQT-ADIA, set to acquire BSV for $1.6 billion
Mumbai: Mankind Pharma, India’s fourth largest pharma ... the latter's drug Vonoprazan in the Indian market. Over FY20-24 gynae (18% of other therapies revenue) registered a 24% CAGR led by ...